Key Insight : Spend on drug treatment within obesity episodes is over 6 times what it was 3 years ago
From cardiovascular and neurodegenerative diseases to chronic kidney disease, osteoarthritis, liver health, sleep apnea, addiction, and fertility issues, these medications offer new hope for managing complex health conditions and improving patient lives
SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1
This weight reduction is substantial and noteworthy, especially considering that many conventional weight loss methods yield far less significant results
The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: an integrative review of evidence, mechanisms, and clinical implications
In-clinic glutathione IV therapy is typically more affordable than mobile or at-home glutathione IV services due to lower staffing and logistics costs